KristenM.MarksMD
Infectious Disease • New York, NYAssistant Professor, Medicine, Weill Cornell Medical College
Dr. Marks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
525 E 68th St Ste J314
New York, NY 10021Phone+1 212-746-7200- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 2002 - 2005- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1999 - 2002
Columbia University Vagelos College of Physicians and SurgeonsClass of 1999
Certifications & Licensure
NY State Medical License 2001 - 2025
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
Clinical Trials
- Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection Start of enrollment: 2005 Mar 01
- Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance Start of enrollment: 2009 Mar 01
- HCV Seek, Test and Rapid Treatment for Young PWID Start of enrollment: 2018 Sep 18
- Join now to see all
Publications & Presentations
PubMed
- 4 citations"Treated like a Human Being": perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City.Shashi N Kapadia, Yesenia Aponte-Melendez, Alicia Rodriguez, Melinda Pai, Benjamin J Eckhardt, Kristen M Marks, Chunki Fong, Pedro Mateu-Gelabert> ;Harm Reduction Journal. 2023 Jul 27
- 4 citationsImmunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus.Kristen M Marks, Minhee Kang, Triin Umbleja, Anchalee Avihingsanon, Patcharaphan Sugandhavesa, Andrea L Cox, Karen Vigil, Hugo Perazzo, Jennifer C Price, Leolin Katsid...> ;Clinical Infectious Diseases. 2023 Aug 14
- 7 citationsLongitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons.Malavika Prabhu, Yawei J Yang, Carrie D Johnston, Elisabeth A Murphy, Thomas J Ketas, Randy Diaz-Tapia, Magdalena Jurkiewicz, Sabrina Racine-Brzostek, Iman Mohammed, A...> ;American Journal of Obstetrics & Gynecology MFM. 2023 Feb 1
- Join now to see all
Journal Articles
- Benefit of Early Versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis Among People with HIV in the START Randomized TrialFred Gordin, Kristen Marks, Hepatology
Press Mentions
IDSA: Three-Dose Hepatitis B Vaccine Highly Protective in Persons with HIVOctober 26th, 2022- People with HIV Can Be Protected Against Hepatitis B with a Three-Dose Vaccine RegimenOctober 24th, 2022
- Accessible Care Key to Treating Hepatitis C in People Who Inject DrugsApril 7th, 2022
- Join now to see all
Grant Support
- Thrombocytopenia &Hiv/Hcv: Risk Factors &TreatmentNational Institute Of Allergy And Infectious Diseases2005–2009
- Safety/Efficacy Of IV Anti-D For Treatment Of Thrombocytopenia In HCVNational Center For Research Resources2005–2007
Hospital Affiliations
New York-Presbyterian HospitalNew York, New York
NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
